Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis are the three major bacterial pathogens causing a variety of community-acquired infections, predominantly respiratory tract infections (16) . Increasing resistance to ␤-lactam antibiotics, macrolides, and/or trimethoprim-sulfamethoxazole (TMP-SMX) among clinical isolates of the three pathogens has been widely documented in many countries, particularly in Taiwan (2, 3, 6-8, 10, 11) . The high rate of antimicrobial resistance among these isolates compromises the choice of antibiotics available for empiric treatment of infections caused by these organisms. The aim of the present study was to describe the susceptibilities of S. pneumoniae, H. influenzae, and M. catarrhalis in a nationwide, prospective, antimicrobial resistance surveillance study. All consecutive clinical isolates (from November 1998 to May 1999, winter to early spring) were collected from patients with community-acquired infections at five hospitals in three different regions of Taiwan: the northern region (National Taiwan University Hospital [NTUH] , Taipei, and Chang Gung Memorial Hospital [CGMH]), the central region (Veterans General Hospital, Taichung [VGH-Taichung]), and the southern region (National Cheng-Kung University Hospital, Tainan, and Veterans General Hospital, Kaohsiung [VGHKaohsiung]). These institutions are all teaching hospitals and vary in size from 1,200 beds to more than 2,000 beds.
A total of 678 isolates of S. pneumoniae (267 isolates), H. influenzae (301), and M. catarrhalis (110) were collected during a 7-month period. The majority (86.4%) of these isolates was recovered from respiratory tract secretions (sputum, bronchial washing fluid, and ear and sinus secretions), and 8.8% of the isolates were recovered from blood, cerebrospinal fluid, pleural effusion, and ascites fluid. The identity of these isolates was further confirmed at the Microbiology Laboratory of NTUH.
MICs for these isolates were determined at the Microbiology Laboratory of NTUH by using the Etest (AB Biodisk, Solna, Sweden) according to the manufacturer's instructions. (12) . When the MIC read between the traditional log 2 concentrations, the result was rounded up to the next value and then interpreted. Production of ␤-lactamase was assayed by using the Cefinase disk test (Becton Dickinson Microbiology Systems, Cockeysville, Md.).
MICs of antimicrobial agents for the five control strains were within the MIC ranges provided by the NCCLS (12) . In vitro susceptibilities of this collection of S. pneumoniae, H. influenzae, and M. catarrhalis isolates to 15 selected antimicrobial agents are shown in Table 1 . Seventy-six percent of S. pneumoniae isolates were penicillin nonsusceptible, 51% were penicillin intermediate, and 25% showed full resistance to penicillin. Fifty-six percent of the H. influenzae isolates produced ␤-lactamase, as did nearly all M. catarrhalis isolates (95.7%). Five isolates (1.7%) of H. influenzae were ␤-lactamase negative and amoxicillin resistant (MICs, 8 to 16 g/ml). Macrolides had remarkably poor activities against S. pneumoniae isolates (the MIC at which 90% of the isolates were inhibited [MIC 90 ] was Ͼ256 g/ml) and H. influenzae isolates (MIC 90 , 16 g/ml for clarithromycin and 8 g/ml for azithromycin) but had good potency against the M. catarrhalis isolates (MIC 90 , 0.38 g/ml for clarithromycin and 0.094 g/ml for azithromycin). More than 50% of S. pneumoniae and H. influenzae were nonsusceptible to TMP-SMX. All quinolones tested were the most active agents against the three pathogens tested, including penicillinnonsusceptible and extended-spectrum cephalosporin-nonsusceptible S. pneumoniae, amoxicillin-resistant H. influenzae, and M. catarrhalis. For one multidrug-resistant S. pneumoniae isolate (penicillin MIC of 4 g/ml and azithromycin MIC of Ͼ256 g/ml), MICs of ofloxacin (Ͼ32 g/ml), grepafloxacin (Ͼ256 g/ml), sparfloxacin (Ͼ256 g/ml), trovafloxacin (Ͼ32 g/ml), and levofloxacin (Ͼ32 g/ml) were higher.
Higher percentages of S. pneumoniae nonsusceptible to aminopenicillins, extended-spectrum cephalosporins, macrolides, and TMP-SMX were observed among penicillin-interme- ; fully resistant, 7%) to ceftriaxone, and nearly all (97 to 99%) were fully resistant to cefuroxime and macrolides. Table 3 shows the incidence of antimicrobial resistance to S. pneumoniae and H. influenzae in the five hospitals. The incidence of penicillin-nonsusceptible S. pneumoniae isolates ranged from 67 to 84%; the highest rate of full resistance was found in CGMH (38%). The highest rates of TMP-SMX-nonsusceptible S. pneumoniae and H. influenzae isolates were both observed in VGH-Kaohsiung, and the lowest rate of macrolide-nonsusceptible H. influenzae was observed in NTUH. ␤-Lactamase production in H. influenzae isolates ranged from 40% in NTUH to 71% in VGH-Kaohsiung. The incidence of macrolide resistance was higher in the central region than in the other two regions.
Comparison of our results with reported resistance rates of the three species demonstrated by recent surveillance data from other countries showed significantly higher rates in Taiwan of penicillin, extended-spectrum cephalosporins, TMP-SMX, and macrolide resistance among S. pneumoniae, as well as significantly higher rates of ␤-lactamase production and macrolide resistance among H. influenzae isolates (1, 4, 5, 15, 16) . However, the prevalence of ␤-lactamase production among M. catarrhalis isolates was uniform among isolates from Taiwan (95.7%), the United States (92.0%), and Canada (93.0%) (5). The major concern is the continuing upsurge in Taiwan of S. pneumoniae isolates nonsusceptible to penicillin (from 61% in 1996-1997 to 76% in 1998-1999) and to clarithromycin (89% in 1996-1997 to 95% in 1998-1999) and of H. influenzae isolates nonsusceptible to azithromycin (from 4.8% in 1994-1995 to 31% in 1998-1999) and to TMP-SMX (from 33.8% in 1994-1995 to 52% in 1998-1999) (8, 11) . Moreover, this study is the first to report ␤-lactamase-negative and amoxicillin-resistant H. influenzae isolates in Taiwan, though such organisms have been reported in the rest of the world (11, 14) . However, a decrease in the rate of nonsusceptibility to TMP-SMX for S. pneumoniae was found (87% in 1996-1997 to 65% in 1998-1999) (8) .
Clinical isolates of S. pneumoniae resistant to newer fluoroquinolones with notable activity against gram-positive bacteria are rare, and this has been demonstrated to be due to mutations in the quinolone resistance-determining regions of the DNA gyrase and topoisomerase IV genes (9, 13) . In the pres- ent study, one isolate of multidrug-resistant S. pneumoniae was also resistant to the five quinolones tested, which had MICs remarkably higher than those reported previously. Further study will be performed to elucidate the resistance mechanism of the isolate.
In conclusion, our data not only present a general view of the incidence of resistance in recent isolates of three major respiratory tract pathogens in Taiwan but also emphasize the increasing incidence of penicillin and macrolide resistance in S. pneumoniae and macrolide resistance in H. influenzae isolates. Increases in resistance, together with remarkable geographical variations in resistance patterns, make local and ongoing antimicrobial susceptibility surveillance crucial in establishing and/or modifying guidelines for the empiric treatment of respiratory tract infections caused by these three pathogens.
